Beaconoi 비코노이

Home  ›  Programs  ›  R&D · Technology

R&D · Technology D-41

2026 Support Program for Advanced Bio Industry Activation Using Bioprinting (Facility & Equipment Utilization) - Beneficiary Company Recruitment

Utilize advanced facilities such as GMP spaces and 3D bioprinters at the Bioprinting Artificial Organ Commercialization Support Center with up to 15 million KRW in actual cost support.

Eligible
SMEs, research institutes, universities, and hospitals in the domestic bioprinting and artificial organ industries
Deadline
2026.11.30

This program supports facility and equipment usage fees at the Bioprinting Artificial Organ Commercialization Support Center for SMEs, research institutes, and others in the domestic bioprinting and artificial organ sectors. Applications are accepted on a first-come, first-served basis until November 30, 2026, or until the budget is exhausted.

3-second summary

  • Target: SMEs, research institutes, universities, and hospitals in the domestic bioprinting and artificial organ industries
  • Support Content: Subsidy for facility and equipment usage fees at the Bioprinting Artificial Organ Commercialization Support Center (actual cost reimbursement)
  • Limit: Total project cost of 30 million KRW, with maximum support of 15 million KRW
  • Application Period: From announcement date to Nov 30, 2026 (First-come, first-served until budget exhaustion)

Eligibility checklist

  • SMEs, research institutes, universities, and hospitals in the domestic bioprinting and artificial organ industries
  • Individual or corporate business operators whose main business address (as per business registration certificate) is located in Korea

Schedule & how to apply

  • Deadline: Nov 30, 2026
  • Application Method: Email submission (Pohang Technopark Green Bio Industry Team)

Recommended for

  • Recommended for CEOs of domestic SMEs and research institutions conducting research or preparing for commercialization in bioprinting and artificial organs.

Frequently asked questions

Who is eligible to apply?

This program is for SMEs, research institutes, universities, and hospitals in the domestic bioprinting and artificial organ industries. Details: SMEs, research institutes, universities, and hospitals in the domestic bioprinting and artificial organ industries; Individual or corporate business operators whose main business address (as per business registration certificate) is located in Korea.

When is the application deadline?

The application deadline is 2026.11.30. Schedules may change — confirm against the official program notice.

How do I apply?

Applications follow the official program notice, which is in Korean. See the source link for the method and receiving office; Beaconoi can prepare an English draft for your review.

Last updated · Source: official program notice

※ Program information is compiled from each institution’s public sources; actual eligibility, amounts and deadlines may change. Always verify against the official notice (in Korean) before applying.

More R&D · Technology programs

See all R&D · Technology programs →